How big is Aligos Therapeutics, Inc.?

Jun 22 2025 06:14 PM IST
share
Share Via
As of Jun 18, Aligos Therapeutics, Inc. has a market capitalization of 46.04 million, with net sales of 3.27 million and a net profit of -53.26 million over the last four quarters. The company's shareholder's funds are -28.97 million, and total assets are 71.85 million.
Market Cap:
As of Jun 18, Aligos Therapeutics, Inc. has a market capitalization of 46.04 million, categorizing it as a Micro Cap company.

Recent Quarterly Performance:
For the latest four quarters, Aligos Therapeutics reported net sales of 3.27 million and a net profit of -53.26 million.

Balance Sheet Snapshot:
As of Dec 24, the company's shareholder's funds amounted to -28.97 million, while total assets were reported at 71.85 million.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is Aligos Therapeutics, Inc. overvalued or undervalued?
Sep 20 2025 06:39 PM IST
share
Share Via
Is Aligos Therapeutics, Inc. overvalued or undervalued?
Jun 25 2025 09:18 AM IST
share
Share Via
What does Aligos Therapeutics, Inc. do?
Jun 22 2025 07:01 PM IST
share
Share Via